These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8757355)
1. Plasma levels of thrombomodulin in pulmonary hypertension. Cacoub P; Karmochkine M; Dorent R; Nataf P; Piette JC; Godeau P; Gandjbakhch I; Boffa MC Am J Med; 1996 Aug; 101(2):160-4. PubMed ID: 8757355 [TBL] [Abstract][Full Text] [Related]
2. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559 [TBL] [Abstract][Full Text] [Related]
3. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy. Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038 [TBL] [Abstract][Full Text] [Related]
4. Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension. D'Alto M; Romeo E; Argiento P; Motoji Y; Correra A; Di Marco GM; Iacono AM; Barracano R; D'Andrea A; Rea G; Sarubbi B; Russo MG; Naeije R Chest; 2017 Jan; 151(1):119-126. PubMed ID: 27575357 [TBL] [Abstract][Full Text] [Related]
5. Serum cardiac troponin I concentration in dogs with precapillary and postcapillary pulmonary hypertension. Guglielmini C; Civitella C; Diana A; Di Tommaso M; Cipone M; Luciani A J Vet Intern Med; 2010; 24(1):145-52. PubMed ID: 20002552 [TBL] [Abstract][Full Text] [Related]
6. Distinction Between Precapillary and Postcapillary Pulmonary Hypertension by the Atrial Volume Ratio on Transthoracic Echocardiography. Saito N; Kato S; Saito N; Nakachi T; Fukui K; Kosuge M; Kimura K J Ultrasound Med; 2018 Apr; 37(4):891-896. PubMed ID: 28960484 [TBL] [Abstract][Full Text] [Related]
8. A simple echocardiographic score for the diagnosis of pulmonary vascular disease in heart failure. D'Alto M; Romeo E; Argiento P; Pavelescu A; D'Andrea A; Di Marco GM; Mattera Iacono A; Sarubbi B; Rea G; Bossone E; Russo MG; Naeije R J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):237-243. PubMed ID: 27841823 [TBL] [Abstract][Full Text] [Related]
9. The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension. Kaiser R; Frantz C; Bals R; Wilkens H Respir Res; 2016 Jul; 17(1):96. PubMed ID: 27473366 [TBL] [Abstract][Full Text] [Related]
10. Effect of Pulmonary Hypertension Hemodynamic Presentation on Clinical Outcomes in Patients With Severe Symptomatic Aortic Valve Stenosis Undergoing Transcatheter Aortic Valve Implantation: Insights From the New Proposed Pulmonary Hypertension Classification. O'Sullivan CJ; Wenaweser P; Ceylan O; Rat-Wirtzler J; Stortecky S; Heg D; Spitzer E; Zanchin T; Praz F; Tüller D; Huber C; Pilgrim T; Nietlispach F; Khattab AA; Carrel T; Meier B; Windecker S; Buellesfeld L Circ Cardiovasc Interv; 2015 Jul; 8(7):e002358. PubMed ID: 26156149 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710 [TBL] [Abstract][Full Text] [Related]
12. Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension. Khush KK; De Marco T; Vakharia KT; Harmon C; Fineman JR; Chatterjee K; Michaels AD J Card Fail; 2006 Sep; 12(7):507-13. PubMed ID: 16952783 [TBL] [Abstract][Full Text] [Related]
13. Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension: A Possible Novel Therapeutic Target. Satoh T; Satoh K; Yaoita N; Kikuchi N; Omura J; Kurosawa R; Numano K; Al-Mamun E; Siddique MA; Sunamura S; Nogi M; Suzuki K; Miyata S; Morser J; Shimokawa H Circ Res; 2017 Apr; 120(8):1246-1262. PubMed ID: 28289017 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. Karmochkine M; Cacoub P; Dorent R; Laroche P; Nataf P; Piette JC; Boffa MC; Gandjbakhch I J Rheumatol; 1996 Feb; 23(2):286-90. PubMed ID: 8882033 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure. Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263 [TBL] [Abstract][Full Text] [Related]
16. Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Amabile N; Heiss C; Real WM; Minasi P; McGlothlin D; Rame EJ; Grossman W; De Marco T; Yeghiazarians Y Am J Respir Crit Care Med; 2008 Jun; 177(11):1268-75. PubMed ID: 18310479 [TBL] [Abstract][Full Text] [Related]
17. Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension. Michaels AD; Chatterjee K; De Marco T J Card Fail; 2005 Aug; 11(6):425-31. PubMed ID: 16105633 [TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 and functional tissue factor: a possible relationship with severity in primary pulmonary hypertension. Collados MT; Velázquez B; Borbolla JR; Sandoval J; Massó F; Montaño LF; Guarner V Heart Vessels; 2003 Mar; 18(1):12-7. PubMed ID: 12644876 [TBL] [Abstract][Full Text] [Related]